A Vingiani

Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.

G Pruneri, A. Goldhirsch, G. Pruneri, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy

S Michiels, S Adams, S Loi, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.